HoldingsChannel.com



Corvus Pharmaceuticals insider buying image
The table below summarizes the most recent Corvus Pharmaceuticals insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why Corvus Pharmaceuticals insider buys are important for investors to follow.
DateInsiderPriceAmount
5-15-2023
Insider Buy		 Linda Grais
 $2.45
CAGR » 		$24,500.00
10,000 shares
12-20-2022
Insider Buy		 William Benton Jones
See Remarks		 $0.79
CAGR » 		$15,800.00
20,000 shares
9-28-2022
Insider Buy		 Richard A. Miller, M.D.
President and CEO		 $0.76
CAGR » 		$19,070.00
25,000 shares
9-20-2022
Insider Buy		 Richard A. Miller, M.D.
President and CEO		 $0.81
CAGR » 		$16,253.23
20,000 shares
6-27-2022
Insider Buy		 Richard A. Miller, M.D.
President and CEO		 $1.01
CAGR » 		$10,134.50
10,000 shares
6-6-2022
Insider Buy		 Richard A. Miller, M.D.
President and CEO		 $0.98
CAGR » 		$5,797.20
5,890 shares
3-17-2022
Insider Buy		 Richard A. Miller, M.D.
President and CEO		 $1.49
CAGR » 		$44,600.00
30,000 shares
3-17-2022
Insider Buy		 Leiv Lea
Chief Financial Officer		 $1.57
CAGR » 		$77,045.10
49,038 shares
8-20-2021
Insider Buy		 Richard A. Miller, M.D.
President and CEO		 $1.93
CAGR » 		$19,254.00
10,000 shares
2-17-2021
Insider Buy		 Richard A. Miller, M.D.
President and CEO		 $3.50
CAGR » 		$350,000.00
100,000 shares
8-6-2019
Insider Buy		 ORBIMED ADVISORS LLC
Director and >10% Owner		 $3.51
CAGR » 		$500,722.56
142,656 shares
8-6-2019
Insider Buy		 Peter A. Thompson
Director and >10% Owner		 $3.51
CAGR » 		$500,722.56
142,656 shares
8-7-2019
Insider Buy		 Richard A. Miller, M.D.
President and CEO		 $3.56
CAGR » 		$26,725.00
7,500 shares
6-14-2019
Insider Buy		 Richard A. Miller, M.D.
President and CEO		 $3.41
CAGR » 		$40,873.80
12,000 shares
6-7-2019
Insider Buy		 Leiv Lea
Chief Financial Officer		 $3.49
CAGR » 		$88,980.00
25,500 shares
12-27-2018
Insider Buy		 Richard A. Miller, M.D.
President and CEO		 $3.29
CAGR » 		$65,884.00
20,000 shares
12-21-2018
Insider Buy		 Leiv Lea
Chief Financial Officer		 $4.15
CAGR » 		$102,408.67
24,700 shares
12-20-2018
Insider Buy		 Richard A. Miller, M.D.
President and CEO		 $4.39
CAGR » 		$43,950.00
10,000 shares
12-6-2018
Insider Buy		 Richard A. Miller, M.D.
President and CEO		 $5.99
CAGR » 		$29,934.00
5,000 shares
12-4-2018
Insider Buy		 Richard A. Miller, M.D.
President and CEO		 $5.95
CAGR » 		$8,936.90
1,502 shares
3-12-2018
Insider Buy		 ORBIMED ADVISORS LLC
Director and >10% Owner		 $8.50
CAGR » 		$4,999,997.50
588,235 shares
3-12-2018
Insider Buy		 Peter A. Thompson
Director and >10% Owner		 $8.50
CAGR » 		$4,999,997.50
588,235 shares
3-12-2018
Insider Buy		 Holdings A/S Novo
>10% Owner		 $8.50
CAGR » 		$9,999,995.00
1,176,470 shares
3-12-2018
Insider Buy		 Terry P. Gould
Director and >10% Owner		 $8.50
CAGR » 		$4,999,997.50
588,235 shares
3-12-2018
Insider Buy		 ADAMS STREET PARTNERS LLC
>10% Owner		 $8.50
CAGR » 		$4,999,997.50
588,235 shares
11-20-2017
Insider Buy		 Richard A. Miller, M.D.
President and CEO		 $10.79
CAGR » 		$107,850.00
10,000 shares
6-23-2017
Insider Buy		 Holdings A/S Novo
>10% Owner		 $10.95
CAGR » 		$219,000.00
20,000 shares
6-13-2017
Insider Buy		 Richard A. Miller, M.D.
President and CEO		 $9.88
CAGR » 		$247,083.62
25,000 shares
6-24-2016
Insider Buy		 ORBIMED ADVISORS LLC
Director and >10% Owner		 $12.98
CAGR » 		$12,983.00
1,000 shares
6-24-2016
Insider Buy		 Peter A. Thompson
Director and >10% Owner		 $12.98
CAGR » 		$12,983.00
1,000 shares
6-21-2016
Insider Buy		 ORBIMED ADVISORS LLC
Director and >10% Owner		 $12.74
CAGR » 		$489,192.21
38,383 shares
6-21-2016
Insider Buy		 Peter A. Thompson
Director and >10% Owner		 $12.74
CAGR » 		$489,192.21
38,383 shares
6-16-2016
Insider Buy		 ORBIMED ADVISORS LLC
Director and >10% Owner		 $12.35
CAGR » 		$247,000.00
20,000 shares
6-16-2016
Insider Buy		 Peter A. Thompson
Director and >10% Owner		 $12.35
CAGR » 		$247,000.00
20,000 shares
6-10-2016
Insider Buy		 ORBIMED ADVISORS LLC
Director and >10% Owner		 $12.96
CAGR » 		$648,100.00
50,000 shares
6-10-2016
Insider Buy		 Peter A. Thompson
Director and >10% Owner		 $12.96
CAGR » 		$648,100.00
50,000 shares
5-20-2016
Insider Buy		 Peter A. Thompson
Director and >10% Owner		 $13.09
CAGR » 		$61,732.44
4,716 shares
5-20-2016
Insider Buy		 ORBIMED ADVISORS LLC
Director and >10% Owner		 $13.09
CAGR » 		$61,732.44
4,716 shares
5-19-2016
Insider Buy		 ORBIMED ADVISORS LLC
Director		 $11.77
CAGR » 		$80,035.04
6,800 shares
5-19-2016
Insider Buy		 Peter A. Thompson
Director and >10% Owner		 $11.77
CAGR » 		$80,035.04
6,800 shares
5-13-2016
Insider Buy		 Richard A. Miller, M.D.
President and CEO		 $10.00
CAGR » 		$302,981.01
30,300 shares
5-12-2016
Insider Buy		 A/S Novo
>10% Owner		 $10.00
CAGR » 		$700,000.00
70,000 shares
3-29-2016
Insider Buy		 A/S Novo
>10% Owner		 $15.00
CAGR » 		$9,999,990.00
666,666 shares
3-29-2016
Insider Buy		 ORBIMED ADVISORS LLC
Director and >10% Owner		 $15.00
CAGR » 		$8,250,000.00
550,000 shares
3-29-2016
Insider Buy		 ADAMS STREET PARTNERS LLC
>10% Owner		 $15.00
CAGR » 		$3,000,000.00
200,000 shares
3-29-2016
Insider Buy		 Peter A. Thompson
Director and >10% Owner		 $15.00
CAGR » 		$8,250,000.00
550,000 shares
3-29-2016
Insider Buy		 Terry P. Gould
Director and >10% Owner		 $15.00
CAGR » 		$3,000,000.00
200,000 shares

Also See: Institutional Holders of CRVS
Also See: SEC filings

CRVS Performance Since Insider Purchase
Below we present the annualized performance delivered by Corvus Pharmaceuticals stock since 5-15-2023 (the date of the most recent insider purchase). The performance of the investment from the time Corvus Pharmaceuticals insider buying occurred is the ultimate test of whether insiders were right about CRVS being a good buy.

Growth of $10,000.00
Without Dividends Reinvested
Start date: 05/16/2023
End date: 04/22/2024
Start price/share: $2.37
End price/share: $1.44
Dividends collected/share: $0.00
Total return: -39.24%
Annualized Gain: -41.88%
Starting investment: $10,000.00
Ending investment: $6,076.00
Years: 0.94

Corvus Pharmaceuticals Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Corvus Pharmaceuticals insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding CRVS

CRVS — Current Quote
Quotes delayed 20 minutes

Email EnvelopeFree CRVS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

CRVS — Performance

Corvus Pharmaceuticals Insider Buying | www.HoldingsChannel.com

Copyright © 2013 - 2024, All Rights Reserved Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.